… physicians to treat prostate cancer and benign prostatic hyperplasia (“BPH”, also … development of TULSA-PRO through participation in the TACT pivotal clinical trial … . Food and Drug Administration (“FDA”). Profound is … treatment of uterine fibroids and has FDA …

UCHealth Longs Peak Hospital in Longmont, Colo., is using a robot-assisted procedure that incorporates AI to treat benign prostatic hyperplasia, or BPH, a common condition among older men. The procedure, known as aquablation, uses a concentrated, heat-free …

… 2 trial (NCT05683691), in which treatment with … Benign-Prostatic-Hyperplasia-BPH.html 6. FDA approves two oral therapies to treat … fda.gov/drugs/resources-information-approved-drugs/fda … News release. Sprout Pharmaceuticals. December 15, 2025. …

… benign prostatic hyperplasia (BPH) in 2025 has been exciting, with several new treatment … trial in December 2025.2 In June 2025, the FDA … preoperative evaluation, guideline development, and prostate artery … drug eluting bioabsorbable implants for treatment …

… ; these members must have also developed metastatic prostate cancer and… and frequent urination often mimic benign prostatic hyperplasia. Learn more about the presentation … also experience extended effects from treatment, whereas late-onset disease is …

… under supportive treatment and pharmaceutical intervention.5 … medications such as hormones and antioxidants, there is currently no specific pharmaceutical … utilized for color development, the cell nuclei … fresh approach for treating ALI and inflammatory …

… stent for the treatment of patients with benign prostatic hyperplasia (BPH), ProVerum Limited … announced in a news release.1 "FDA … -line interventional therapy to treat BPH," noted global lead …

… , Kaplan highlights that the ProVIDE trial demonstrated mostly mild and transient … as a practical, office-based BPH treatment option.

… months of pharmacological treatment and met … three groups developed postoperative stress … treating large-volume BPH, with comparable improvements in LUTS, urinary flow, and medication … Guidelines for the treatment of benign prostatic hyperplasia. US Pharm. …

… past decade, 4 BPH stents have received FDA approval, with 2 … expansion of office-based treatment options. Zorn places the … aging male population, increasing BPH prevalence, and workforce limitations … the growing complexity of treatment selection as the MIST …